Stereotaxis, Inc. (STXS)
AMEX · Healthcare
$1.50-3.23%
As of Jul 20, 2026
Price history
Key statistics
- Market cap
- $151.49M
- P/E ratio
- —
- EPS
- —
- Volume
- 1,742,459
- 52-week high
- —
- 52-week low
- —
- Open
- $1.55
- Day high
- $1.63
- Day low
- $1.49
Financial highlights
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| 2025 | $32.38M | -$21.64M | -$0.25 |
| 2024 | $26.92M | -$24.05M | -$0.30 |
| 2023 | $26.77M | -$20.71M | -$0.27 |
| 2022 | $28.15M | -$18.29M | -$0.26 |
| 2021 | $35.02M | -$10.72M | -$0.16 |
About Stereotaxis, Inc.
Stereotaxis, Inc. designs, manufactures and markets robotic magnetic navigation systems for use in a hospital's interventional surgical suite to enhance the treatment of arrhythmias and coronary artery disease. Its products include the Genesis RMN System, the Odyssey Solution, and related devices. The firm also offers the Stereotaxis Imaging Model S x-ray System. The company was founded in June 1990 and is headquartered in St. Louis, MO.
- CEO
- David L. Fischel
- Employees
- 131
- Country
- US
- IPO date
- Aug 12, 2004
Similar stocks
Other Healthcare companies
Frequently asked questions
- What is Stereotaxis, Inc.'s stock price today?
- STXS is trading at $1.50 as of Jul 20, 2026.
- What is Stereotaxis, Inc.'s market cap?
- Stereotaxis, Inc. (STXS) has a market capitalization of $151.49M.
- Does Stereotaxis, Inc. pay a dividend?
- Stereotaxis, Inc. did not pay a dividend in its most recent reported fiscal year.
- What sector is Stereotaxis, Inc. in?
- Stereotaxis, Inc. operates in the Healthcare sector.